Prosight Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-195,217
Closed -$13.1M 46
2025
Q3
$13.1M Buy
195,217
+125,217
+179% +$9.91M 3.06% 13
2025
Q2
$6.11M Buy
+70,000
New +$5.49M 1.49% 22
2024
Q4
Sell
-160,000
Closed -$10.7M 40
2024
Q3
$10.7M Buy
160,000
+110,683
+224% +$9.09M 2.64% 15
2024
Q2
$5.59M Buy
49,317
+26,317
+114% +$3.33M 1.67% 23
2024
Q1
$3.19M Hold
23,000
0.89% 30
2023
Q4
$2.85M Sell
23,000
-39,421
-63% -$4.03M 1.15% 23
2023
Q3
$5.82M Buy
+62,421
New +$7.04M 1.85% 18
2018
Q2
Sell
-260,000
Closed -$4.82M 32
2018
Q1
$4.82M Buy
260,000
+135,208
+108% +$2M 3.02% 13
2017
Q4
$1.79M Buy
+124,792
New +$1.62M 1.32% 23

Other funds holding DXCM

Prosight Management's DXCM Position: Q4 2025 in Review

Prosight Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 195,217 shares — an estimated $13.1M sold.

Prosight Management first reported a position in DXCM in Q4 2017 and held it in 9 quarters. The position peaked at $13.1M in Q3 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Prosight Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Prosight Management sold 195,217 DexCom shares in Q4 2025, an estimated $13.1M.
  • Prosight Management first reported a position in DexCom in Q4 2017 and held it in 9 quarters.
  • Prosight Management's DexCom position peaked at $13.1M in Q3 2025.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Prosight Management's 13F filing for Q4 2025, filed 13 Feb 2026.